{"metadata":{"kernelspec":{"language":"python","display_name":"Python 3","name":"python3"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[],"dockerImageVersionId":31192,"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"# This Python 3 environment comes with many helpful analytics libraries installed\n# It is defined by the kaggle/python Docker image: https://github.com/kaggle/docker-python\n# For example, here's several helpful packages to load\n\nimport numpy as np # linear algebra\nimport pandas as pd # data processing, CSV file I/O (e.g. pd.read_csv)\n\n# Input data files are available in the read-only \"../input/\" directory\n# For example, running this (by clicking run or pressing Shift+Enter) will list all files under the input directory\n\nimport os\nfor dirname, _, filenames in os.walk('/kaggle/input'):\n    for filename in filenames:\n        print(os.path.join(dirname, filename))\n\n# You can write up to 20GB to the current directory (/kaggle/working/) that gets preserved as output when you create a version using \"Save & Run All\" \n# You can also write temporary files to /kaggle/temp/, but they won't be saved outside of the current session","metadata":{"_uuid":"8f2839f25d086af736a60e9eeb907d3b93b6e0e5","_cell_guid":"b1076dfc-b9ad-4769-8c92-a6c4dae69d19","trusted":true},"outputs":[],"execution_count":null},{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"âœ… Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"ðŸ”‘ Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:57:04.184088Z","iopub.execute_input":"2025-11-13T14:57:04.185023Z","iopub.status.idle":"2025-11-13T14:57:04.234194Z","shell.execute_reply.started":"2025-11-13T14:57:04.184983Z","shell.execute_reply":"2025-11-13T14:57:04.233368Z"}},"outputs":[{"name":"stdout","text":"âœ… Gemini API key setup complete.\n","output_type":"stream"}],"execution_count":10},{"cell_type":"code","source":"from typing import Any, Dict\n\nfrom google.adk.agents import Agent, LlmAgent\nfrom google.adk.apps.app import App, EventsCompactionConfig\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.sessions import DatabaseSessionService\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.runners import Runner\nfrom google.adk.tools.tool_context import ToolContext\nfrom google.genai import types\n\nprint(\"âœ… ADK components imported successfully.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:45:25.035854Z","iopub.execute_input":"2025-11-13T14:45:25.036141Z","iopub.status.idle":"2025-11-13T14:46:11.352454Z","shell.execute_reply.started":"2025-11-13T14:45:25.036118Z","shell.execute_reply":"2025-11-13T14:46:11.351342Z"}},"outputs":[{"name":"stdout","text":"âœ… ADK components imported successfully.\n","output_type":"stream"}],"execution_count":2},{"cell_type":"code","source":"async def run_session(\n    runner_instance: Runner,\n    user_queries: list[str] | str = None,\n    session_name: str = \"default\",\n):\n    print(f\"\\n ### Session: {session_name}\")\n\n    # Get app name from the Runner\n    app_name = runner_instance.app_name\n\n    # Attempt to create a new session or retrieve an existing one\n    try:\n        session = await session_service.create_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n    except:\n        session = await session_service.get_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n\n    # Process queries if provided\n    if user_queries:\n        # Convert single query to list for uniform processing\n        if type(user_queries) == str:\n            user_queries = [user_queries]\n\n        # Process each query in the list sequentially\n        for query in user_queries:\n            print(f\"\\nUser > {query}\")\n\n            # Convert the query string to the ADK Content format\n            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n            # Stream the agent's response asynchronously\n            async for event in runner_instance.run_async(\n                user_id=USER_ID, session_id=session.id, new_message=query\n            ):\n                # Check if the event contains valid content\n                if event.content and event.content.parts:\n                    # Filter out empty or \"None\" responses before printing\n                    if (\n                        event.content.parts[0].text != \"None\"\n                        and event.content.parts[0].text\n                    ):\n                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n    else:\n        print(\"No queries!\")\n\n\nprint(\"âœ… Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:57:39.104918Z","iopub.execute_input":"2025-11-13T14:57:39.105227Z","iopub.status.idle":"2025-11-13T14:57:39.114063Z","shell.execute_reply.started":"2025-11-13T14:57:39.105202Z","shell.execute_reply":"2025-11-13T14:57:39.113074Z"}},"outputs":[{"name":"stdout","text":"âœ… Helper functions defined.\n","output_type":"stream"}],"execution_count":12},{"cell_type":"code","source":"retry_config = types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1,\n    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:47:05.936093Z","iopub.execute_input":"2025-11-13T14:47:05.936951Z","iopub.status.idle":"2025-11-13T14:47:05.941913Z","shell.execute_reply.started":"2025-11-13T14:47:05.936916Z","shell.execute_reply":"2025-11-13T14:47:05.940714Z"}},"outputs":[],"execution_count":5},{"cell_type":"code","source":"APP_NAME = \"default\"  # Application\nUSER_ID = \"default\"  # User\nSESSION = \"default\"  # Session\n\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n\n# Step 1: Create the LLM Agent\nroot_agent = Agent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot\",  # Description of the agent's purpose\n)\n\n# Step 2: Set up Session Management\n# InMemorySessionService stores conversations in RAM (temporary)\nsession_service = InMemorySessionService()\n\n# Step 3: Create the Runner\nrunner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Stateful agent initialized!\")\nprint(f\"   - Application: {APP_NAME}\")\nprint(f\"   - User: {USER_ID}\")\nprint(f\"   - Using: {session_service.__class__.__name__}\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:50:34.556576Z","iopub.execute_input":"2025-11-13T14:50:34.556922Z","iopub.status.idle":"2025-11-13T14:50:34.564430Z","shell.execute_reply.started":"2025-11-13T14:50:34.556899Z","shell.execute_reply":"2025-11-13T14:50:34.563579Z"}},"outputs":[{"name":"stdout","text":"âœ… Stateful agent initialized!\n   - Application: default\n   - User: default\n   - Using: InMemorySessionService\n","output_type":"stream"}],"execution_count":6},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\n        \"Hi, I am Sam! What is the capital of United States?\",\n        \"Hello! What is my name?\",  # This time, the agent should remember!\n    ],\n    \"stateful-agentic-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:57:47.342555Z","iopub.execute_input":"2025-11-13T14:57:47.343395Z","iopub.status.idle":"2025-11-13T14:57:49.056523Z","shell.execute_reply.started":"2025-11-13T14:57:47.343363Z","shell.execute_reply":"2025-11-13T14:57:49.055602Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > Hi, I am Sam! What is the capital of United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  You told me your name is Sam.\n","output_type":"stream"}],"execution_count":13},{"cell_type":"code","source":"chatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:58:27.559862Z","iopub.execute_input":"2025-11-13T14:58:27.560206Z","iopub.status.idle":"2025-11-13T14:58:27.668978Z","shell.execute_reply.started":"2025-11-13T14:58:27.560183Z","shell.execute_reply":"2025-11-13T14:58:27.667739Z"}},"outputs":[{"name":"stdout","text":"âœ… Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":14},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:58:41.698394Z","iopub.execute_input":"2025-11-13T14:58:41.698898Z","iopub.status.idle":"2025-11-13T14:58:43.201606Z","shell.execute_reply.started":"2025-11-13T14:58:41.698871Z","shell.execute_reply":"2025-11-13T14:58:43.200417Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > Hi, I am Sam! What is the capital of the United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":15},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:58:57.583690Z","iopub.execute_input":"2025-11-13T14:58:57.584014Z","iopub.status.idle":"2025-11-13T14:58:58.546697Z","shell.execute_reply.started":"2025-11-13T14:58:57.583990Z","shell.execute_reply":"2025-11-13T14:58:58.545583Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > What is the capital of India?\ngemini-2.5-flash-lite >  The capital of India is New Delhi.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":16},{"cell_type":"code","source":"import sqlite3\n\ndef check_data_in_db():\n    with sqlite3.connect(\"my_agent_data.db\") as connection:\n        cursor = connection.cursor()\n        result = cursor.execute(\n            \"select app_name, session_id, author, content from events\"\n        )\n        print([_[0] for _ in result.description])\n        for each in result.fetchall():\n            print(each)\n\n\ncheck_data_in_db()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:59:25.058185Z","iopub.execute_input":"2025-11-13T14:59:25.058614Z","iopub.status.idle":"2025-11-13T14:59:25.065635Z","shell.execute_reply.started":"2025-11-13T14:59:25.058586Z","shell.execute_reply":"2025-11-13T14:59:25.064713Z"}},"outputs":[{"name":"stdout","text":"['app_name', 'session_id', 'author', 'content']\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n","output_type":"stream"}],"execution_count":17},{"cell_type":"code","source":"research_app_compacting = App(\n    name=\"research_app_compacting\",\n    root_agent=chatbot_agent,\n    # This is the new part!\n    events_compaction_config=EventsCompactionConfig(\n        compaction_interval=3,  # Trigger compaction every 3 invocations\n        overlap_size=1,  # Keep 1 previous turn for context\n    ),\n)\n\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Create a new runner for our upgraded app\nresearch_runner_compacting = Runner(\n    app=research_app_compacting, session_service=session_service\n)\n\n\nprint(\"âœ… Research App upgraded with Events Compaction!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T14:59:48.243071Z","iopub.execute_input":"2025-11-13T14:59:48.243388Z","iopub.status.idle":"2025-11-13T14:59:48.253182Z","shell.execute_reply.started":"2025-11-13T14:59:48.243364Z","shell.execute_reply":"2025-11-13T14:59:48.252327Z"}},"outputs":[{"name":"stdout","text":"âœ… Research App upgraded with Events Compaction!\n","output_type":"stream"},{"name":"stderr","text":"/tmp/ipykernel_48/4205090295.py:5: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n  events_compaction_config=EventsCompactionConfig(\n","output_type":"stream"}],"execution_count":18},{"cell_type":"code","source":"await run_session(\n    research_runner_compacting,\n    \"What is the latest news about AI in healthcare?\",\n    \"compaction_demo\",\n)\n\n# Turn 2\nawait run_session(\n    research_runner_compacting,\n    \"Are there any new developments in drug discovery?\",\n    \"compaction_demo\",\n)\n\n# Turn 3 - Compaction should trigger after this turn!\nawait run_session(\n    research_runner_compacting,\n    \"Tell me more about the second development you found.\",\n    \"compaction_demo\",\n)\n\n# Turn 4\nawait run_session(\n    research_runner_compacting,\n    \"Who are the main companies involved in that?\",\n    \"compaction_demo\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T15:00:10.558408Z","iopub.execute_input":"2025-11-13T15:00:10.559481Z","iopub.status.idle":"2025-11-13T15:00:33.671335Z","shell.execute_reply.started":"2025-11-13T15:00:10.559444Z","shell.execute_reply":"2025-11-13T15:00:33.670255Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: compaction_demo\n\nUser > What is the latest news about AI in healthcare?\ngemini-2.5-flash-lite >  Here's a summary of some of the latest news and trends in AI in healthcare:\n\n**Key Areas of Advancement & Recent Developments:**\n\n*   **AI for Drug Discovery and Development:** This remains a hot area. Companies are using AI to:\n    *   **Identify novel drug targets:** Analyzing vast biological datasets to pinpoint molecules or pathways involved in diseases.\n    *   **Design new drug molecules:** Predicting the efficacy and safety of potential drug candidates.\n    *   **Accelerate clinical trials:** Optimizing trial design, identifying suitable patient cohorts, and predicting outcomes.\n    *   **Recent examples:** Companies like Recursion Pharmaceuticals, Insilico Medicine, and Atomwise continue to make headlines with their AI-driven platforms and drug candidates entering clinical trials.\n\n*   **Diagnostic Imaging with AI:** AI algorithms are becoming increasingly sophisticated at analyzing medical images (X-rays, CT scans, MRIs, pathology slides).\n    *   **Early detection:** Identifying subtle signs of diseases like cancer, diabetic retinopathy, and cardiovascular issues that might be missed by the human eye.\n    *   **Improved accuracy and efficiency:** Assisting radiologists and pathologists by flagging potential abnormalities and prioritizing urgent cases.\n    *   **Examples:** AI is being used for lung nodule detection, breast cancer screening, and identifying strokes from brain scans.\n\n*   **Personalized Medicine and Treatment:** AI is crucial for tailoring treatments to individual patients.\n    *   **Genomic analysis:** Interpreting complex genomic data to understand disease risk and predict treatment response.\n    *   **Predictive analytics:** Identifying patients at higher risk for certain conditions or complications, allowing for proactive interventions.\n    *   **Treatment optimization:** Recommending the most effective therapies based on a patient's unique profile.\n\n*   **AI in Clinical Workflow and Operations:** Beyond direct patient care, AI is streamlining healthcare operations.\n    *   **Administrative tasks:** Automating tasks like scheduling, billing, and prior authorizations, reducing burnout for staff.\n    *   **Patient monitoring:** Using AI-powered wearables and remote monitoring devices to track patient health outside of traditional settings.\n    *   **Virtual assistants and chatbots:** Providing patients with information, answering FAQs, and helping with appointment booking.\n\n*   **Generative AI in Healthcare (Emerging Trend):** Large Language Models (LLMs) are beginning to make a significant impact.\n    *   **Clinical documentation:** Summarizing patient visits, drafting clinical notes, and generating discharge instructions.\n    *   **Medical education and research:** Creating realistic medical scenarios for training, and assisting with literature reviews.\n    *   **Patient communication:** Developing more sophisticated chatbots that can understand and respond to complex patient queries.\n    *   **Caution:** While promising, there are ongoing discussions about the accuracy, bias, and ethical implications of generative AI in clinical settings.\n\n**Challenges and Considerations:**\n\n*   **Data Privacy and Security:** Protecting sensitive patient data is paramount.\n*   **Regulatory Hurdles:** Gaining FDA and other regulatory approvals for AI-powered medical devices and software can be a complex process.\n*   **Bias in AI Algorithms:** Ensuring that AI models are trained on diverse datasets to avoid perpetuating existing healthcare disparities.\n*   **Integration into Existing Workflows:** Seamlessly integrating AI tools into the busy and complex environments of hospitals and clinics.\n*   **Trust and Adoption:** Building trust among healthcare professionals and patients in AI-driven solutions.\n*   **Explainability (XAI):** The need for AI models to be able to explain their reasoning, especially in critical decision-making.\n\n**To get the absolute *latest* news, you would typically look at:**\n\n*   **Major Medical Journals:** *The Lancet*, *NEJM*, *JAMA*, *Nature Medicine* often publish groundbreaking AI research.\n*   **Tech and Healthcare News Outlets:** Websites like *STAT News*, *FierceBiotech*, *Healthcare Dive*, *TechCrunch*, and *VentureBeat* frequently cover AI in healthcare.\n*   **Conferences and Industry Events:** Major AI and healthcare conferences (e.g., HIMSS, RSNA, NeurIPS) are where much of the cutting-edge work is presented.\n\nIn summary, AI in healthcare is rapidly evolving, with significant progress in drug discovery, diagnostics, personalized medicine, and operational efficiency. Generative AI is the newest frontier, offering exciting possibilities but also presenting new challenges that need careful consideration.\n\n ### Session: compaction_demo\n\nUser > Are there any new developments in drug discovery?\ngemini-2.5-flash-lite >  Yes, there are **constant and significant new developments** in AI-driven drug discovery. It's one of the most dynamic areas within AI in healthcare. Here are some of the key trends and recent advancements:\n\n**1. Generative AI for Novel Molecule Design:**\n*   **What's new:** Generative models (like GANs, VAEs, and now increasingly, diffusion models and large language models adapted for molecular structures) are not just identifying existing compounds but are actively **designing entirely new molecules** with desired properties from scratch.\n*   **How it works:** These models learn the \"grammar\" of molecular structures and can generate novel compounds that are predicted to bind to specific targets, have favorable pharmacokinetic properties (absorption, distribution, metabolism, excretion), and be less toxic.\n*   **Impact:** This dramatically expands the chemical space researchers can explore, potentially leading to breakthrough therapies that wouldn't have been conceived through traditional methods.\n\n**2. Enhanced Target Identification and Validation:**\n*   **What's new:** AI is being used to sift through massive datasets â€“ genomics, proteomics, transcriptomics, electronic health records (EHRs), and scientific literature â€“ to identify **novel disease targets** with unprecedented speed and accuracy.\n*   **How it works:** Machine learning algorithms can spot complex patterns and correlations that indicate a particular protein, gene, or pathway is critically involved in a disease. This helps prioritize targets that are most likely to yield effective drugs.\n*   **Impact:** This reduces the time and cost associated with the very first step of drug discovery, which has historically been a major bottleneck.\n\n**3. Predictive Modeling for Efficacy and Toxicity:**\n*   **What's new:** AI models are getting better at **predicting how well a drug candidate will work** and its potential side effects *before* it even reaches costly and time-consuming preclinical or clinical trials.\n*   **How it works:** These models analyze data from previous drug development efforts, in vitro assays, and even animal studies to forecast success rates and identify potential liabilities early on.\n*   **Impact:** This significantly de-risks the drug development process, saving resources and accelerating the path for promising candidates.\n\n**4. AI in Clinical Trial Optimization:**\n*   **What's new:** While not strictly \"discovery,\" AI is revolutionizing how drugs are tested. This includes:\n    *   **Patient stratification:** Identifying specific patient subgroups who are most likely to respond to a drug.\n    *   **Trial design:** Optimizing trial protocols for efficiency.\n    *   **Predicting trial outcomes:** Forecasting the likelihood of success based on early data.\n    *   **Decentralized trials:** Using AI to manage and monitor remote patient participation.\n*   **Impact:** Faster, more efficient, and more successful clinical trials.\n\n**5. Use of Large Language Models (LLMs) and Natural Language Processing (NLP):**\n*   **What's new:** LLMs are being employed to extract actionable insights from vast amounts of unstructured text data, such as scientific papers, patents, and clinical trial reports.\n*   **How it works:** NLP can identify relationships between genes, diseases, drugs, and biological pathways, helping researchers uncover hidden connections and formulate new hypotheses.\n*   **Impact:** Accelerates knowledge synthesis and can lead to serendipitous discoveries.\n\n**Examples of Companies and Their Work (not exhaustive):**\n\n*   **Recursion Pharmaceuticals:** Uses AI and automation to map human cellular responses, identify drug targets, and discover new therapies.\n*   **Insilico Medicine:** Known for its AI platform that has discovered and advanced several novel drug candidates, including one for idiopathic pulmonary fibrosis that entered human trials.\n*   **Atomwise:** Utilizes deep learning for structure-based drug design, predicting how small molecules will bind to proteins.\n*   **BenevolentAI:** Employs AI to analyze biomedical data for target identification and drug discovery.\n*   **Exscientia:** Focuses on AI-driven drug design and has successfully brought AI-designed drugs into clinical trials.\n\n**Key Recent Developments to Watch For:**\n\n*   **Focus on rare diseases and neglected diseases:** AI's ability to analyze vast datasets can be particularly helpful in identifying potential treatments for conditions with limited existing research.\n*   **Integration of multi-omics data:** Combining genomics, proteomics, metabolomics, and other \"omics\" data with AI for a more holistic understanding of disease.\n*   **Explainable AI (XAI) in drug discovery:** While the \"black box\" nature of some AI can be powerful, there's a growing push for models that can explain their predictions, increasing trust and allowing scientists to learn from the AI's reasoning.\n\nIn essence, AI is transforming drug discovery from a process often described as trial-and-error and serendipity to a more systematic, predictive, and accelerated endeavor. The pace of innovation is extremely high, making it a truly exciting field.\n\n ### Session: compaction_demo\n\nUser > Tell me more about the second development you found.\ngemini-2.5-flash-lite >  You're likely referring to the second development I mentioned: **Enhanced Target Identification and Validation.** This is a crucial and rapidly advancing area in AI-driven drug discovery.\n\nLet me elaborate on why it's so important and how AI is making a difference:\n\n**The Traditional Challenge of Target Identification:**\n\nHistorically, identifying the right biological target (like a specific protein or gene) for a drug has been one of the most challenging, time-consuming, and expensive phases of drug discovery.\n\n*   **Complexity of Biology:** Human biology is incredibly complex. Diseases often arise from intricate interactions between multiple genes, proteins, and cellular pathways.\n*   **Data Overload:** Researchers have access to an ever-increasing volume of biological data (genomics, proteomics, transcriptomics, metabolomics, clinical data). Sifting through this data manually to find meaningful connections is incredibly difficult.\n*   **\"Undruggable\" Targets:** Many potentially good targets were historically considered \"undruggable\" because we didn't understand them well enough or lacked the tools to interact with them.\n*   **High Failure Rate:** A significant percentage of drug candidates fail in later stages because the initial target was not as central to the disease as initially thought, or the biological rationale was flawed.\n\n**How AI is Revolutionizing Target Identification:**\n\nAI, particularly machine learning and deep learning, excels at finding patterns, making connections, and processing vast amounts of data, which are precisely the skills needed to overcome the traditional challenges.\n\n1.  **Analyzing Multi-Omics Data:**\n    *   **What it is:** AI algorithms can integrate and analyze data from different biological \"omics\" layers simultaneously â€“ like genomics (DNA), transcriptomics (RNA), proteomics (proteins), and metabolomics (metabolites).\n    *   **How AI helps:** It can identify how changes in one layer (e.g., a genetic mutation) affect other layers and ultimately lead to disease pathways. This creates a more comprehensive picture of disease mechanisms than analyzing each layer in isolation.\n    *   **Example:** An AI might identify a specific gene mutation (genomics) that leads to an overproduction of a certain protein (proteomics), which in turn disrupts a cellular process (transcriptomics), ultimately causing a disease symptom.\n\n2.  **Mining Scientific Literature and Databases:**\n    *   **What it is:** There's an enormous amount of published scientific research, clinical trial data, and patent information.\n    *   **How AI helps:** Natural Language Processing (NLP) and machine learning models can \"read\" and interpret this unstructured text data. They can identify associations between genes, proteins, diseases, and existing drugs that human researchers might miss. This can uncover novel hypotheses or validate existing ones.\n    *   **Example:** An AI could scan thousands of research papers on Alzheimer's disease and identify a less-studied protein that is consistently mentioned in association with key pathological processes, suggesting it could be a new therapeutic target.\n\n3.  **Leveraging Real-World Data (RWD) and Electronic Health Records (EHRs):**\n    *   **What it is:** AI can analyze anonymized patient data from EHRs, insurance claims, and patient registries.\n    *   **How AI helps:** By looking at patient populations, AI can identify correlations between genetic predispositions, disease progression, and treatment responses. This can help pinpoint targets that are relevant to diverse patient populations or identify subtypes of a disease.\n    *   **Example:** An AI might analyze EHR data to find that patients with a specific genetic marker are more likely to develop a severe form of a particular autoimmune disease, highlighting a potential target for intervention in that subgroup.\n\n4.  **Network Biology and Systems Thinking:**\n    *   **What it is:** Diseases rarely affect just one molecule; they impact complex biological networks.\n    *   **How AI helps:** AI can build models of these biological networks and simulate how different perturbations (like a drug intervention) might affect the entire system. This allows researchers to identify \"master regulator\" nodes or points of intervention that can have a broad impact on the disease.\n    *   **Example:** Instead of targeting a single protein, AI might suggest targeting a key \"hub\" protein in a signaling pathway that, when modulated, can correct multiple downstream dysfunctions.\n\n**The Impact of AI in Target Identification:**\n\n*   **Speed:** AI can analyze data and generate hypotheses in days or weeks, compared to months or years for traditional methods.\n*   **Novelty:** AI can uncover non-obvious connections and identify targets that might not have been considered through human intuition alone.\n*   **Validation:** AI can help strengthen the biological rationale for a target by providing evidence from multiple data sources.\n*   **Reduced Failure Rates:** By identifying more robust and relevant targets upfront, AI can contribute to a higher success rate in downstream drug development.\n\nCompanies like **BenevolentAI**, **Atomwise**, **Recursion Pharmaceuticals**, and **Insilico Medicine** (among many others) are heavily invested in using AI for target identification as a foundational step in their drug discovery pipelines. It's a testament to how fundamental this advancement is to the entire drug development process.\n\n ### Session: compaction_demo\n\nUser > Who are the main companies involved in that?\ngemini-2.5-flash-lite >  You're asking about the key players in **AI-driven drug discovery, specifically focusing on the \"enhanced target identification and validation\" aspect**, but it's important to understand that many companies working on AI drug discovery touch upon target ID as a core part of their platform.\n\nHere are some of the prominent companies, categorized by their general approach, though there's significant overlap:\n\n**1. Platforms Focused Heavily on Target ID & Validation (Often using integrated data & AI):**\n\n*   **BenevolentAI:** This company is a prime example. They have built a vast knowledge graph that integrates scientific literature, clinical trial data, patent information, and proprietary biological data. Their AI algorithms mine this graph to identify novel drug targets and then predict therapeutic hypotheses.\n*   **Recursion Pharmaceuticals:** Recursion uses automated biological experiments (high-throughput screening of cells) coupled with advanced imaging and machine learning to map cellular responses to various perturbations. This allows them to discover novel targets and understand disease mechanisms at a cellular level, which informs target identification.\n*   **Exscientia:** While known for AI-driven molecule design, Exscientia's platform also excels at identifying and prioritizing novel targets by analyzing complex biological data and understanding the disease context before designing therapeutics.\n\n**2. Companies Using Generative AI and ML for Molecule Design (which inherently requires target identification first):**\n\n*   **Insilico Medicine:** They have a comprehensive AI platform that spans target discovery, molecule design, and clinical development. Their AI has identified novel targets and then designed molecules against them, as seen with their idiopathic pulmonary fibrosis drug candidate.\n*   **Atomwise:** Focuses on using deep learning (a form of AI) to predict how small molecules will bind to protein targets. To do this effectively, they need robust methods for identifying and characterizing these protein targets first.\n*   **SchrÃ¶dinger:** While a long-standing leader in physics-based computational chemistry, SchrÃ¶dinger has significantly integrated AI and machine learning into its platform. This allows for more sophisticated target analysis and helps guide their molecule design efforts.\n\n**3. Biotech/Pharma Companies with Significant In-House AI Investments:**\n\nMany large pharmaceutical companies are building their own AI capabilities or partnering with AI-native companies. They are investing in AI for target identification, drug design, and clinical trial optimization. Examples include:\n\n*   **Pfizer:** Has made significant investments in AI and machine learning across its R&D pipeline, including target identification.\n*   **Novartis:** A leader in adopting computational approaches, Novartis has been active in AI for drug discovery, including target ID.\n*   **Roche/Genentech:** Have a strong history of leveraging data and computational tools, increasingly integrating AI for target validation and drug discovery.\n*   **Sanofi:** Actively pursuing AI partnerships and internal development for drug discovery.\n*   **AstraZeneca:** Has been very vocal about its AI strategy, including using AI to discover and validate novel drug targets.\n\n**4. Smaller & Emerging AI Drug Discovery Companies:**\n\nThe field is constantly evolving, with new startups emerging regularly. Many of these focus on specific niches within AI drug discovery, which often includes advanced target ID:\n\n*   **Nurix Therapeutics:** While more focused on protein degradation, their approach often involves identifying novel E3 ligases as targets.\n*   **Deep Genomics:** Uses AI to identify disease-causing genetic mutations and then develop therapies (often RNA-based) to correct them, which fundamentally relies on accurate target identification at the genetic level.\n*   **Relay Therapeutics:** Focuses on understanding protein motion and dynamics, which can reveal novel targets and mechanisms of action.\n\n**Key Themes in These Companies' Approaches:**\n\n*   **Data Integration:** They all emphasize the importance of integrating diverse data sources (genomics, proteomics, literature, clinical data).\n*   **Proprietary AI Algorithms:** Each company develops or utilizes unique machine learning and deep learning models tailored to biological data.\n*   **Focus on Specific Disease Areas:** Many companies specialize in certain therapeutic areas (e.g., oncology, neurodegeneration, rare diseases).\n*   **Bridging the Gap:** The ultimate goal is to bridge the gap between understanding disease biology and developing effective drugs, with target identification being the critical first step.\n\nIt's worth noting that the landscape is very fluid. Companies merge, get acquired, and new players emerge frequently. However, the companies listed above are consistently recognized for their significant contributions and innovative approaches in leveraging AI for drug discovery, including target identification.\n","output_type":"stream"}],"execution_count":19},{"cell_type":"code","source":"final_session = await session_service.get_session(\n    app_name=research_runner_compacting.app_name,\n    user_id=USER_ID,\n    session_id=\"compaction_demo\",\n)\n\nprint(\"--- Searching for Compaction Summary Event ---\")\nfound_summary = False\nfor event in final_session.events:\n    # Compaction events have a 'compaction' attribute\n    if event.actions and event.actions.compaction:\n        print(\"\\nâœ… SUCCESS! Found the Compaction Event:\")\n        print(f\"  Author: {event.author}\")\n        print(f\"\\n Compacted information: {event}\")\n        found_summary = True\n        break\n\nif not found_summary:\n    print(\n        \"\\nâŒ No compaction event found. Try increasing the number of turns in the demo.\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T15:22:24.058616Z","iopub.execute_input":"2025-11-13T15:22:24.059049Z","iopub.status.idle":"2025-11-13T15:22:24.083947Z","shell.execute_reply.started":"2025-11-13T15:22:24.058993Z","shell.execute_reply":"2025-11-13T15:22:24.082956Z"}},"outputs":[{"name":"stdout","text":"--- Searching for Compaction Summary Event ---\n\nâœ… SUCCESS! Found the Compaction Event:\n  Author: user\n\n Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='99687cea-afbd-4afd-bf04-c767f19ad9da' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763046010.591567, 'end_timestamp': 1763046020.75971, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'This conversation focused on the latest news in AI in healthcare, specifically delving into developments in AI-driven drug discovery.\\n\\n**Key Information and Decisions:**\\n\\n*   The AI provided a broad overview of AI in healthcare, highlighting advancements in drug discovery, diagnostic imaging, personalized medicine, clinical workflow, and the emerging role of generative AI.\\n*   Challenges and considerations such as data privacy, regulatory hurdles, bias, integration, trust, and explainability were also discussed.\\n*   The user specifically requested more information on \"Enhanced Target Identification and Validation\" within drug discovery.\\n*   The AI elaborated on this topic, explaining the traditional challenges of target identification and detailing how AI is revolutionizing it through:\\n    *   Analyzing multi-omics data.\\n    *   Mining scientific literature and databases.\\n    *   Leveraging real-world data (RWD) and Electronic Health Records (EHRs).\\n    *   Employing network biology and systems thinking.\\n*   The impact of AI in target identification was summarized as increased speed, novelty, validation, and reduced failure rates.\\n*   Several companies actively involved in AI for drug discovery were mentioned as examples.\\n\\n**Unresolved Questions or Tasks:**\\n\\n*   None. The conversation concluded with the AI providing a detailed explanation of the user\\'s specific query regarding target identification.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='b4396491-91e1-461d-a689-f07aceb1b298' timestamp=1763046028.730356\n","output_type":"stream"}],"execution_count":20},{"cell_type":"code","source":"USER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n\n\n# This demonstrates how tools can write to session state using tool_context.\n# The 'user:' prefix indicates this is user-specific data.\ndef save_userinfo(\n    tool_context: ToolContext, user_name: str, country: str\n) -> Dict[str, Any]:\n    \"\"\"\n    Tool to record and save user name and country in session state.\n\n    Args:\n        user_name: The username to store in session state\n        country: The name of the user's country\n    \"\"\"\n    # Write to session state using the 'user:' prefix for user data\n    tool_context.state[\"user:name\"] = user_name\n    tool_context.state[\"user:country\"] = country\n\n    return {\"status\": \"success\"}\n\n\n# This demonstrates how tools can read from session state.\ndef retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n    \"\"\"\n    Tool to retrieve user name and country from session state.\n    \"\"\"\n    # Read from session state\n    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n    country = tool_context.state.get(\"user:country\", \"Country not found\")\n\n    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n\n\nprint(\"âœ… Tools created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T15:24:36.744032Z","iopub.execute_input":"2025-11-13T15:24:36.744390Z","iopub.status.idle":"2025-11-13T15:24:36.753255Z","shell.execute_reply.started":"2025-11-13T15:24:36.744365Z","shell.execute_reply":"2025-11-13T15:24:36.752334Z"}},"outputs":[{"name":"stdout","text":"âœ… Tools created.\n","output_type":"stream"}],"execution_count":21},{"cell_type":"code","source":"APP_NAME = \"default\"\nUSER_ID = \"default\"\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n# Create an agent with session state tools\nroot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"\"\"A text chatbot.\n    Tools for managing user context:\n    * To record username and country when provided use `save_userinfo` tool. \n    * To fetch username and country when required use `retrieve_userinfo` tool.\n    \"\"\",\n    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n)\n\n# Set up session service and runner\nsession_service = InMemorySessionService()\nrunner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n\nprint(\"âœ… Agent with session state tools initialized!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T15:30:47.711998Z","iopub.execute_input":"2025-11-13T15:30:47.712334Z","iopub.status.idle":"2025-11-13T15:30:47.720131Z","shell.execute_reply.started":"2025-11-13T15:30:47.712308Z","shell.execute_reply":"2025-11-13T15:30:47.719111Z"}},"outputs":[{"name":"stdout","text":"âœ… Agent with session state tools initialized!\n","output_type":"stream"}],"execution_count":23},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\n        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n        \"My name is Sam. I'm from Poland.\",  # Provide name - agent should save it\n        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n    ],\n    \"state-demo-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T15:55:38.379672Z","iopub.execute_input":"2025-11-13T15:55:38.380032Z","iopub.status.idle":"2025-11-13T15:55:41.701386Z","shell.execute_reply.started":"2025-11-13T15:55:38.380009Z","shell.execute_reply":"2025-11-13T15:55:41.700185Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: state-demo-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing well, thank you for asking. I can't recall your name at the moment. Can you please tell me what it is? If you'd like me to remember it for future conversations, I can save it along with your country.\n\nUser > My name is Sam. I'm from Poland.\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  It's nice to meet you, Sam! I'll remember that you're from Poland.\ngemini-2.5-flash-lite >  I've saved your information. How else may I assist you today?\n\nUser > What is my name? Which country am I from?\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  Your name is Sam and you are from Poland.\n","output_type":"stream"}],"execution_count":24},{"cell_type":"code","source":"session = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n)\n\nprint(\"Session State Contents:\")\nprint(session.state)\nprint(\"\\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T15:56:28.359417Z","iopub.execute_input":"2025-11-13T15:56:28.359797Z","iopub.status.idle":"2025-11-13T15:56:28.366442Z","shell.execute_reply.started":"2025-11-13T15:56:28.359775Z","shell.execute_reply":"2025-11-13T15:56:28.365555Z"}},"outputs":[{"name":"stdout","text":"Session State Contents:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\n","output_type":"stream"}],"execution_count":25},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi there, how are you doing today? What is my name?\"],\n    \"new-isolated-session\",\n)\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T15:56:46.163574Z","iopub.execute_input":"2025-11-13T15:56:46.163875Z","iopub.status.idle":"2025-11-13T15:56:47.066558Z","shell.execute_reply.started":"2025-11-13T15:56:46.163854Z","shell.execute_reply":"2025-11-13T15:56:47.065431Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: new-isolated-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  I'm doing great, thank you for asking! I'd love to tell you your name, but I don't have that information stored. Could you tell me what it is?\n","output_type":"stream"}],"execution_count":26},{"cell_type":"code","source":"session = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n)\n\nprint(\"New Session State:\")\nprint(session.state)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T15:57:12.073115Z","iopub.execute_input":"2025-11-13T15:57:12.073415Z","iopub.status.idle":"2025-11-13T15:57:12.078830Z","shell.execute_reply.started":"2025-11-13T15:57:12.073392Z","shell.execute_reply":"2025-11-13T15:57:12.077772Z"}},"outputs":[{"name":"stdout","text":"New Session State:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n","output_type":"stream"}],"execution_count":27},{"cell_type":"code","source":"import os\n\nif os.path.exists(\"my_agent_data.db\"):\n    os.remove(\"my_agent_data.db\")\nprint(\"âœ… Cleaned up old database files\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-13T15:57:36.528482Z","iopub.execute_input":"2025-11-13T15:57:36.529589Z","iopub.status.idle":"2025-11-13T15:57:36.535007Z","shell.execute_reply.started":"2025-11-13T15:57:36.529556Z","shell.execute_reply":"2025-11-13T15:57:36.533973Z"}},"outputs":[{"name":"stdout","text":"âœ… Cleaned up old database files\n","output_type":"stream"}],"execution_count":28}]}